4th Circ. Denies Eli Lilly's Discovery Bid In Novartis IP Feud

By Jasmin Boyce · June 16, 2022, 8:53 PM EDT

The Fourth Circuit on Thursday affirmed a Virginia district court's decision denying Eli Lilly's discovery bid related to Novartis' European patent suit over Eli Lilly's psoriasis drug Taltz, agreeing that Novartis...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Eli Lilly and Company v. Novartis Pharma AG

Case Number

22-1094

Court

Appellate - 4th Circuit

Nature of Suit

3890 Other Statutory Actions

Date Filed

February 02, 2022